Follow the development of Preciphos and the FoRe platform.
Find news, public resources and institutional content related to Preciphos’ development, FoRe technology, medical applications, partnerships and next project milestones.
Preciphos has launched an initial €200,000 seed funding round to accelerate the development of the FoRe platform.
This financing milestone is intended to support the project’s next key stages—including validation, industrialization, and the acquisition of initial references—while preparing for future strategic phases of growth.
A Section Designed to Grow Over Time
Preciphos is developing an ambitious medtech platform whose progress is driven by research, validation, partnerships, industrialization, and engagement with qualified stakeholders.
This section brings together public content that allows visitors to follow this journey, while also providing access points to confidential resources available exclusively through private areas.
News updates, announcements, institutional resources, publications, and presentation materials approved by the Preciphos team.
More detailed, technical, or sensitive materials are available exclusively through private areas following stakeholder qualification.
Key milestones in Preciphos’ development.
This section features public announcements related to the progress of Preciphos, including fundraising activities, partnerships, collaborations, development milestones, industrialization efforts, validation achievements, and participation in professional events.
Updates related to financing milestones and investor development activities.
Approved information regarding medical, scientific, institutional, and industrial collaborations.
Major milestones related to the technology, industrialization process, and application development.
Participation in trade shows, conferences, medtech gatherings, and scientific events.
Content to understand Preciphos, FoRe and its challenges.
These public resources provide essential information about Preciphos, its technology, application areas, and market positioning in a format designed for professional audiences.
Understand the company’s vision, technology, and key development priorities.
Access a concise overview of the immunological analysis platform.
Scientific information to be shared with control.
Certain publications, technical notes, and scientific materials may be shared publicly once their release has been approved. More detailed, confidential, or sensitive information remains reserved for the Scientific Area.
Documents and materials approved by Preciphos for public distribution.
Non-confidential educational content covering the technology and its applications.
More technical or sensitive materials are available exclusively to qualified stakeholders. Confidentiality is an integral part of the Preciphos approach.
A first level of public information, detailed documents in private access.
The public investor page provides an overview of the Preciphos opportunity. More detailed investor materials—including the Executive Summary, One-Pager, and other qualified resources—are reserved for the private Investor Area and shared according to the level of engagement.
Vision, technology, target markets, traction, and overall roadmap—non-confidential information designed to help stakeholders understand the medtech opportunity.
Executive Summary, Investor One-Pager, and qualified investor resources available to stakeholders following a qualification process.
Content Formats Designed to Support the Growth of Preciphos
As the project progresses, this section may host a variety of content formats, aligned with communication priorities and internal validation processes.
Executive summaries, publications, and educational materials explaining the technology.
Non-confidential content covering the business model, target markets, and development roadmap.
Insights and analysis on precision medicine, prevention, and immunological diagnostics.
Are you looking for specific information about Preciphos?
Some resources are publicly available, while others are reserved for qualified stakeholders.
To ensure you receive the most relevant level of information, Preciphos will direct your request according to your profile—whether you are an investor, researcher, healthcare institution, public organization, industrial partner, or member of the media.